We identified CASC3 as a direct target of miR-124-1 and found that miR-124-1 modulates the activity of the p38-ERK-JNK pathway by regulating CASC3 expression, which may play a role in HCC tumorigenesis. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.